China Life Capital
Beijingchinalifeinvest.com
Overview
China Life Capital is the professional alternative investment platform for its parent, the state-owned China Life Insurance (Group) Company. It primarily engages in private equity, real estate, and infrastructure investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tripo AI | Jun 2026 | Series A+ / A++ | Co-investor |
| Cascade Pharmaceuticals, Inc. | Feb 2026 | VC Round | Co-investor |
| Cascade Pharmaceuticals, Inc. | Feb 2026 | Series C | Co-investor |
| Vastai Technologies | Dec 2021 | Series B | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.